Ocuphire Pharma Profit Margin

Ocuphire Pharma posts a profit margin of -2099.71% as of June 2026. That compares with 9429.06% in the prior-year period — down 122.3% year over year. That is below the Healthcare sector average of 9.71%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ocuphire Pharma's profit margin was 9429.06%. The latest reading is -2099.71% — a 122.3% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.71% is typical. Ocuphire Pharma's -2099.71% is lower that level. That is roughly 21733.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Ocuphire Pharma's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -2099.71% as of June 2026; use YoY and peer views to separate noise from signal.

Context for OCUP's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.71%), and (3) consistency with growth and profitability. This page covers the first two; Ocuphire Pharma's other metric pages and overview cover the third.